Related Experiment Videos
Bone marrow purging with dibutyl phthalate--experimental basis and a preliminary clinical application
1Department of Experimental Hematology, Beijing Institute of Radiation Medicine, People's Republic of China.
Leukemia Research
|August 1, 1995
Summary
Di-n-butyl phthalate (DBP) shows new potential for selectively eliminating tumor cells. This was demonstrated in a successful autologous bone marrow transplant for acute myeloid leukemia, restoring blood cell production.
Area of Science:
- Pharmacology
- Hematology
- Oncology
Background:
- Di-n-butyl phthalate (DBP) has recently been identified with novel pharmacological activity.
- This activity involves the selective elimination of tumor cells within bone marrow.
Purpose of the Study:
- To investigate the application of DBP in purging tumor cells from bone marrow.
- To evaluate the efficacy of DBP-purged autologous bone marrow transplantation in a clinical setting.
Main Methods:
- Utilizing long-term liquid culture of bone marrow cells in vitro.
- Employing DBP for selective tumor cell elimination.
- Performing autologous bone marrow transplantation post-DBP purging.
Main Results:
- Successful reconstitution of hematopoiesis was achieved in the patient.
- The treatment was applied to a case of acute myeloid leukemia in first complete remission.
Conclusions:
- DBP purging combined with autologous bone marrow transplantation is a viable strategy.
- This approach shows promise for treating acute myeloid leukemia and potentially other marrow-related cancers.